Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Breast × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 477 Triple Negative Breast Neoplasms 97 Ovarian Neoplasms 51 Carcinoma, Non-Small-Cell Lung 43 Prostatic Neoplasms 37 Colorectal Neoplasms 37 Endometrial Neoplasms 33 Neoplasm Metastasis 32 Neoplasms 30 Lung Neoplasms 30 Melanoma 29 Pancreatic Neoplasms 23 Uterine Cervical Neoplasms 20 Stomach Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Head and Neck Neoplasms 17 Carcinoma, Intraductal, Noninfiltrating 15 Sarcoma 14 Colonic Neoplasms 12 Esophageal Neoplasms 11 Carcinoma, Renal Cell 11 Small Cell Lung Carcinoma 10 Breast Carcinoma In Situ 10 Urinary Bladder Neoplasms 9 Gastrointestinal Neoplasms 9 Brain Neoplasms 9 Liver Neoplasms 8 Urogenital Neoplasms 7 Recurrence 7 Carcinoma, Transitional Cell 7

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡